AN2 Therapeutics, Inc.'s total assets for Q4 2025 were $61.95M, a decrease of -7.86% from the previous quarter. ANTX total liabilities were $8.89M for the fiscal quarter, a 29.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.